Omicia Garners $23,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1625 Clay Street 2nd Floor Oakland, CA 94612 USA
  • Company Description
    Omicia is unlocking the potential of personalized medicine. Our mission is to help researchers and clinicians understand and apply the most relevant information from personal genome sequences, to improve disease management and medical outcomes.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Omicia’s latest financing will be used to fuel acceleration in product development and an expansion in sales, sales support, marketing and operations. In addition, the company plans to extend variations of its flagship OpalTM Clinical platform for use in new geographies and new verticals including life science research, clinical trial support, population health management and consumer applications.
  • M&A Terms
  • Venture Investor
    UPMC Health Plan
  • Venture Investor
    Ping An Group
  • Venture Investor
    ARTIS Ventures
  • Venture Investor
    Roche Venture Fund
  • Venture Investor
    LDV Partners
  • Venture Investor
    Acadia Woods Ventures
  • Venture Investor
    Buchanan Ventures
  • Venture Investor

Trending on Xconomy